These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 37032555

  • 1. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM, Attygalle AD, Croce S, Vroobel K, Oliva E, McCluggage WG.
    Am J Surg Pathol; 2023 Jun 01; 47(6):717-724. PubMed ID: 37032555
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic Value of Combined BCOR, Cyclin D1, and CD10 in Differentiating Endometrial Stromal Sarcoma From Other Uterine Spindle Cell Lesions.
    Abouelkhair MB, Shakweer MM, Faisal MM, Nasreldin MH, Farid LM.
    Appl Immunohistochem Mol Morphol; 2024 Aug 01; 32(7):326-335. PubMed ID: 38961542
    [Abstract] [Full Text] [Related]

  • 3. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G.
    Am J Surg Pathol; 2022 Aug 01; 46(8):1142-1152. PubMed ID: 35499168
    [Abstract] [Full Text] [Related]

  • 4. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A, Lauria A, Przybyl J, Ng TL, Kowalewska M, Debiec-Rychter M, Ganesan R, Sumathi V, George S, McCluggage WG, Nucci MR, Lee CH, Fletcher JA.
    Am J Surg Pathol; 2018 Mar 01; 42(3):335-341. PubMed ID: 29200103
    [Abstract] [Full Text] [Related]

  • 5. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE, Uner A, Usubutun A.
    Int J Surg Pathol; 2023 Aug 01; 31(5):521-531. PubMed ID: 35506912
    [Abstract] [Full Text] [Related]

  • 6. High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities.
    Zou Y, Turashvili G, Soslow RA, Park KJ, Croce S, McCluggage WG, Stewart CJR, Oda Y, Oliva E, Young RH, Da Cruz Paula A, Dessources K, Ashley CW, Hensley ML, Yip S, Weigelt B, Benayed R, Antonescu CR, Lee CH, Chiang S.
    Mod Pathol; 2020 Sep 01; 33(9):1861-1870. PubMed ID: 32317704
    [Abstract] [Full Text] [Related]

  • 7. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S.
    Am J Surg Pathol; 2019 May 01; 43(5):662-669. PubMed ID: 30789359
    [Abstract] [Full Text] [Related]

  • 8. Utility of YWHAE fluorescent in-situ hybridisation in mesenchymal tumors of uterus- An initial experience from tertiary oncology centre in India.
    Verma A, Menon S, Rekhi B, Pai T, Maheshwari A, Ghosh J, Gupta S, Deodhar K.
    Indian J Cancer; 2019 May 01; 56(4):335-340. PubMed ID: 31607703
    [Abstract] [Full Text] [Related]

  • 9. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA.
    Mod Pathol; 2017 Sep 01; 30(9):1251-1261. PubMed ID: 28621321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.
    Kruse AJ, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK.
    Int J Gynecol Cancer; 2014 Nov 01; 24(9):1616-22. PubMed ID: 25244606
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.
    Kommoss FKF, Mar LM, Howitt BE, Hanley K, Turashvilli G, Buslei R, Irving JA, Dickson BC, Koelsche C, Sinn HP, Schirmacher P, von Deimling A, Chiang S, McCluggage WG, Croce S, Stewart CJR, Lee CH.
    Mod Pathol; 2023 Mar 01; 36(3):100044. PubMed ID: 36788095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.